Figure 1.

Liraglutide attenuates myocardial tissue injury in diabetic rats. (A) Quantitative da-ta for the heart weight/body weight (HW/BW) ratio; (B) Representative images of myocar-dium tissue sections stained with hematoxylin-eosin (×400); (C) Representative images of Western blotting; (D) Atrial natriuretic peptide (ANP) and fetal isoform of myosin heavy chain (β-MHC) expression; (E) Serum creatine kinase (CK) levels; (F) Serum lactate dehy-drogenase (LDH) levels. Data are presented as the mean±SEM, n=5–10 per group. ^**P<0.01 vs NC; ^##P<0.01 vs DM

NC: normal control; DM: diabetes mellitus; LRG: liraglutide